Abstract: Succinate dehydrogenase (SDH) is a key mitochondrial enzyme complex composed of 4 subunits. SDH histochemistry is routinely utilized in the assessment of muscle biopsies to reveal underlying pathology such as subsarcolemmal mitochondrial aggregates. In this study, we evaluated the utility of succinate dehydrogenase B (SDHB) immunohistochemistry (IHC) in 27 muscle biopsies, including 13 mitochondrial myopathies (MMs), 9 inflammatory myopathies, and 5 controls. SDHB IHC was performed on formalin-fixed, paraffin-embedded tissue sections with a mouse monoclonal antibody (Abcam 21A11AE7) in parallel with histochemical SDH stains on a fresh-frozen tissue. In all muscle biopsies, SDHB IHC exhibited granular immunoreactivity and highlighted the dark type 1 and lighter type 2 staining pattern observed by histochemistry. In all cases of MM, SDHB IHC showed subsarcolemmal granular aggregates involving the entire periphery of the fibers that were more distinct than those seen by SDH histochemistry. In 3 extraocular muscle biopsies, SDHB immunoreactive speckles of various sizes were distributed throughout the entire sarcoplasm that were more prominent than those seen on SDH histochemistry. Subsarcolemmal and cytoplasmic granular aggregates seen on SDHB IHC correlated with mitochondrial pathology on electron microscopy. In cases of inflammatory myopathy, there was diffuse sarcoplasmic SDHB immunoreactivity in degenerating fibers, but no evidence of subsarcolemmal aggregates. This study demonstrates that SDHB IHC is highly sensitive and specific in the identification of MM. The automation, reproducibility, and cost efficiency of SDHB IHC offer advantages over the labor-intensive histochemical method requiring frozen sections. As this technique is performed on formalin-fixed, paraffin-embedded tissues, it can be easily applied for retrospective studies.
Abstract: Succinate dehydrogenase (SDH) is a key mitochondrial enzyme complex composed of 4 subunits. SDH histochemistry is routinely utilized in the assessment of muscle biopsies to reveal underlying pathology such as subsarcolemmal mitochondrial aggregates. In this study, we evaluated the utility of succinate dehydrogenase B (SDHB) immunohistochemistry (IHC) in 27 muscle biopsies, including 13 mitochondrial myopathies (MMs), 9 inflammatory myopathies, and 5 controls. SDHB IHC was performed on formalin-fixed, paraffin-embedded tissue sections with a mouse monoclonal antibody (Abcam 21A11AE7) in parallel with histochemical SDH stains on a fresh-frozen tissue. In all muscle biopsies, SDHB IHC exhibited granular immunoreactivity and highlighted the dark type 1 and lighter type 2 staining pattern observed by histochemistry. In all cases of MM, SDHB IHC showed subsarcolemmal granular aggregates involving the entire periphery of the fibers that were more distinct than those seen by SDH histochemistry. In 3 extraocular muscle biopsies, SDHB immunoreactive speckles of various sizes were distributed throughout the entire sarcoplasm that were more prominent than those seen on SDH histochemistry. Subsarcolemmal and cytoplasmic granular aggregates seen on SDHB IHC correlated with mitochondrial pathology on electron microscopy. In cases of inflammatory myopathy, there was diffuse sarcoplasmic SDHB immunoreactivity in degenerating fibers, but no evidence of subsarcolemmal aggregates. This study demonstrates that SDHB IHC is highly sensitive and specific in the identification of MM. The automation, reproducibility, and cost efficiency of SDHB IHC offer advantages over the labor-intensive histochemical method requiring frozen sections. As this technique is performed on formalin-fixed, paraffin-embedded tissues, it can be easily applied for retrospective studies. S uccinate dehydrogenase (SDH) is a mitochondrial enzyme complex located in the inner mitochondrial membrane that has dual roles in the oxidation of succinate to fumarate in the Krebs cycle and in electron transport during oxidative phosphorylation. 1 SDH is a heterodimeric complex composed of 4 protein subunits (SDHA, SDHB, SDHC, and SDHD) and SDH assembly factor A2, which is required for stabilization of the SDH complex. 2 SDHA and SDHB form the catalytic core, whereas SDHC and SDHD anchor the complex to the inner mitochondrial membrane. 2 A variety of mitochondrial enzymes, including SDH, may be affected in mitochondrial diseases. These disorders involve tissues generating high amounts of adenosine triphosphate (ATP) in mitochondria, particularly skeletal muscle, myocardiocytes, and neurons. 3 SDH histochemical assay is a key tool in the evaluation of muscle biopsies from patients with mitochondrial myopathies. 4 SDH histochemistry highlights the oxidative capacity of muscle fibers and therefore allows for the differentiation of type 1, or high oxidative capacity (dark staining), and type 2, or low oxidative capacity (light staining), fibers. In addition, abnormal subsarcolemmal mitochondrial aggregates are readily visualized on SDH histochemical stains in cases of mitochondrial myopathies. These abnormal fibers often have the appearance of "ragged-red fibers," a term designated by the appearance on a Gomori trichrome stain. [5] [6] [7] Confirmation of the presence of abnormal mitochondria is usually done by electron microscopy (EM). Characteristic ultrastructural changes include an increased number of mitochondria, altered mitochondrial size, shape, and formation of cristae, and the presence of crystalline or osmiophilic inclusions. 8 SDHB IHC has emerged as a reliable method for diagnosing and screening of SDH-deficient tumors, including SDH-deficient pheochromocytoma/paraganglioma, SDH-deficient gastrointestinal stromal tumor, and SDHdeficient renal cell carcinoma. 9, 10 If any of the SDH subunits are inactivated, the entire complex becomes unstable, resulting in degradation of the SDHB subunit. 10 SDHB IHC may be performed on archival, formalin-fixed paraffin-embedded (FFPE) tissues using a commercially available mouse monoclonal antibody. 10 The goal of this study is to evaluate the staining patterns of SDHB immunoreactivity in muscle biopsies of patients with myopathies and compare these staining patterns to those seen using the traditional SDH histochemical assay.
MATERIALS AND METHODS
Twenty-nine muscle biopsies, including 13 cases of mitochondrial myopathy (MM), 9 cases of inflammatory myopathy (IM; 5 cases of polymyositis and 4 of dermatomyositis), and 5 normal controls were retrieved from the archives of the Departments of Pathology at the Rhode Island Hospital and The Miriam Hospital. Controls were defined as biopsies with no evidence of mitochondrial abnormality and no significant inflammation or other pathologic finding. In the MM group, biopsies were taken most commonly from the quadriceps, but also from the vastus lateralis, gluteus maximus, and posterior neck. In 3 cases of MM, the biopsies were taken from the extraocular levator palpebrae muscle. In the IM group, biopsies were most commonly taken from the deltoid muscle, but also from the quadriceps and gluteus maximus muscles. Biopsies in the control group were taken from the deltoid or quadriceps muscle.
The original hematoxylin and eosin sections were reviewed by 2 pathologists (M.P. and E.G.S.). Diagnoses were supported by adjunctive histochemistry including Gomori trichrome, ATPase, SDH, cytochrome C oxidase (COX), nicotinamide adenine dinucleotide, and immunohistochemical staining for slow and fast myosin using mouse monoclonal antibodies at 1:100 and 1:200 dilution, respectively (clone WB-MHCs at 1:100 and clone WB-MHCf at 1:200 dilution, respectively; Leica, Newcastle, UK) in all cases.
Ultrastructural examination of mitochondria was assessed by EM in all cases of MM. In 2 cases, genomic analysis of mitochondrial DNA was performed.
Histochemical SDH Staining
Histochemical SDH staining was performed on a fresh-frozen tissue. Appropriate cross-sections of muscle were selected, rolled in talc, and submerged in liquid nitrogen. The tissue was then stored in a À 801C freezer until used. All samples were sectioned on a cryostat at 8 to 12 mm. Enzymatic activity of SDH was assayed by placing the slides in SDH incubating solution, containing sodium succinate as a substrate and nitroblue tetrazolium for visualization of reaction for 1 hour at 371C. 11 Reduced nitroblue tetrazolium forms a highly colored formazan dye that is finely granular blue. The pattern of staining was evaluated by light microscopy and compared with control muscle tissue. The staining intensity was scored as strong when speckled pattern of staining was easily detectable at low magnification (Â 40), or as weak when the staining was seen at higher power magnifications (Â 200 and Â 400), but not clearly observed at lower magnifications.
Immunohistochemical SDHB Staining
IHC staining was performed on 4-mm thick FFPE whole-tissue sections using a Dako Autostainer, with a polymer-based detection system and a Dako EnVision FLEX High pH kit (Dako, Carpinteria, CA). A mouse monoclonal antibody against SDHB (clone 21A11AE7; Abcam, Cambridge, MA) was used at a dilution of 1:200. Appropriate positive and negative controls were stained in parallel. Staining results were assessed by 2 pathologists (M.P. and E.G.S.) in a blinded manner. The staining intensity was scored similarly to the histochemical assay.
RESULTS

Clinical Characteristics
The patients included 13 males and 14 females and ranged in age from 3 to 91 years (Table 1) . Most patients had a combination of myopathic features such as weakness, pain, exercise intolerance, or hypotonia. Medical histories were significant in some cases for diabetes, hypertension, obesity, and seizures. Eight patients with MM presented with ptosis or ophthalmoplegia. Of these, 2 were diagnosed with Kearns-Sayre syndrome, a form of mitochondrial myopathy characterized by adult onset chronic progressive external opthalmoplegia. 12 Mitochondrial DNA testing was performed in 1 case, a vastus lateralis biopsy from a 3-year-old girl, and showed a homoplasmic variant, 619 T > C. A second patient, a 47-year-old woman with adult onset motor and sensory neuropathy and myopathy, had a prior diagnosis of mitochondrial DNA polymerase gene mutation.
SDHB Immunohistochemical and SDH Histochemical Staining
In all muscle biopsies including study and control groups, SDHB IHC exhibited granular cytoplasmic staining. SDHB IHC differentially expressed according to the muscle fiber type with stronger immunoreactivity in the type 1 oxidative fibers and weak staining in type 2 nonoxidative fibers in all study groups and in normal controls (Fig. 1A) . This staining pattern closely resembled the type 1 (dark) and type 2 (light) staining seen on SDH histochemistry (Fig. 1B) . In contrast to SDH histochemistry, sarcomeric cross-striations were readily seen on SDHB IHC (Fig. 1A) .
In all cases of MM, SDHB IHC exhibited scattered fibers with strongly immunoreactive subsarcolemmal granular aggregates that were more distinct than those seen by SDH histochemistry (Figs. 1C, D) . The subsarcolemmal aggregates involved the entire periphery of the fibers (Fig. 1C) . In 3 ocular biopsies from the levator palpebral muscle, SDHB immunoreactive speckles of various sizes were distributed throughout the entire sarcoplasm (Fig. 1E) . These speckles were less prominent on SDH histochemistry (Fig. 1F ).
Subsarcolemmal and cytoplasmic granular aggregates seen on SDHB immunostain correlated with mitochondrial pathology on EM. Cases of MM showed classic ultrastructural findings of mitochondrial abnormalities A and B, Fiber-type staining pattern with stronger reactivity in the type 1 oxidative fibers and weak staining in type 2 nonoxidative fibers. Sarcomeric cross-striations were readily seen on SDHB IHC (inset), but not on SDH histostain. C, Strongly immunoreactive subsarcolemmal granular aggregates involving the entire periphery of the fibers in case of mitochondrial myopathy. D, Two fibers with dark-blue subsarcolemmal mitochondrial aggregates on SDH histochemistry in the same case. E, SDHB immunoreactive speckles of various sizes are diffusely distributed throughout the entire sarcoplasm in a case of mitochondrial myopathy biopsied from extraocular muscle. F, These speckles were less prominent on SDH histochemistry in the same case. G, Small degenerative fibers with diffuse rather than granular sarcoplasmic SDHB immunoreactivity in case of inflammatory myopathy, but no subsarcolemmal aggregates. H, SDH histochemistry in the same case with small darker degenerative fiber and fibers with empty spaces as a result of freezing artifact. IHC indicates immunohistochemistry; SDH, succinate dehydrogenase; SDHB, succinate dehydrogenase B.
including increased mitochondrial number, abnormal mitochondrial architecture, and intramitochondrial osmiophilic inclusions.
In cases of IM including both polymyositis and dermatomyositis degenerating fibers were characteristically of smaller size when compared with the neighboring fibers with no degenerative changes (Figs. 1G, H) . There was diffuse sarcoplasmic SDHB immunoreactivity rather than granular SDHB immunoreactivity in degenerating fibers, but none had evidence of subsarcolemmal aggregates (Figs. 1G, H) .
DISCUSSION
We evaluated immunohistochemical SDHB staining in FFPE muscle biopsies of patients with MM, inflammatory myopathies, and normal muscle. We demonstrated that SDHB IHC is highly sensitive and specific and may prove useful for the identification of MM.
SDH plays a vital role by forming a link in the chain of biochemical reactions required for the oxidation of lipids, carbohydrates, and proteins. 13 More than 6 decades ago, Kun and Abood 14 were the first to utilize the tetrazolium compound for the estimation of SDH enzymatic activity. By using the tetrazoilum reagent, Rutenburg et al estimated SDH activity in tissue homogenates. 15 Seligman and Rutenburg 16 showed that SDH enzyme activity may be demonstrated histochemically in frozen sections of heart, kidney, liver, and brain using blue tetrazolium. High enzymatic SDH activity was subsequently found in skeletal muscle and localized to the mitochondria. 17 SDH histochemical staining is now routinely utilized in the assessment of muscle biopsies and provides important information regarding the distribution of skeletal muscle fiber types and the presence of subsarcolemmal mitochondrial aggregates in cases of mitochondrial myopathies. 8 Although this assay is very useful for assessing mitochondrial abnormalities, it has several disadvantages. The histochemical method is more time-consuming and technician-dependent. Indeed the stain has to be prepared just prior to the assay and a prepared batch cannot be stored for later use. In addition, it requires frozen tissue, which may have numerous artifacts if the muscle tissue is frozen too slowly or too quickly. 18 In this study, SDHB IHC on FFPE tissue was found to be a highly sensitive and highly specific in the identification of MM.
Immunohistochemical staining distinguished muscle fiber type with an accuracy very similar to histochemical staining, and is therefore useful for analyzing the distribution of fiber types in skeletal muscle. Moreover, compared with the histochemical staining method, SDHB IHC provided more distinct visualization of mitochondrial aggregates in cases of MM. The automation, reproducibility, and cost efficiency of SDHB offer other advantages over the labor-intensive histochemical approach. The immunohistochemical technique works well on FFPE tissues and can be easily used to perform retrospective archival studies.
Historically, time-consuming methods have been used to differentiate between slow and fast fibers by myosin ATPase activity at different pH levels, 19 and determine the oxidative activity using COX, and nicotinamide adenine dinucleotide in addition to SDH in fresh-frozen muscle tissues. 20, 21 Recently, IHC with fastmyosin antibody became available to provide a faster and more reliable means to identify all fiber types in a singlemuscle section. It is now considered to be the gold standard. 22, 23 COX IHC may provide information on specific COX subunit alterations. 24 SDHB IHC is a reliable alternative to the classic histochemical staining method. As noted above, a further advantage is obtained since these antibodies have a stored shelf-life of 1 year compared with the need to immediately use the histochemical stains that rely on enzymatic activity once they are prepared. Clearly, from a practical standpoint, application of these IHC methodologies provide potential benefits for triaging of tissue and laboratory workflow that translates into overall cost benefits.
In addition to subsarcolemmal mitochondrial aggregates, in 3 ocular biopsies immunoreactive aggregates filled the entire fiber. Although the anatomic pattern of muscle involvement in MM is variable, the extraocular muscles are commonly involved. 3 The reason that extraocular muscles are particularly sensitive to mitochondrial disease is uncertain, but it may be that these muscles have exceptionally high requirements for ATP. In agreement with this, extraocular muscles have the most mitochondria per mass than any other body muscles. This may explain diffuse aggregates of mitochondria seen on SDHB IHC in biopsies from extraocular muscles in this study.
In this study, we did not find decrease or loss of SDHB expression in any of the MM cases. Recently, Alston and colleagues described a child who regressed rapidly after 1 year of age and presented with unsteadiness, repeated falls, eventual loss of walking ability, and loss of muscle tone. 25 A diagnostic muscle biopsy showed severely reduced SDH and complex II activity, and genetic analysis identified a novel homozygous SDHB gene mutation (c.143A > T, p.Asp48Val). Further analysis revealed almost complete absence of the SDHB subunit by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Clearly, it would be of interest to assess cases with mutations in SDHB or other subunits of mitochondrial complex II that lead to deterioration of mitochondrial function by SDHB IHC.
In conclusion, this study expands the diagnostic utility of SDHB IHC from SDH-deficient tumors to nonneoplastic muscle biopsies. SDHB IHC proved to be sensitive and specific for identification of MM and should be considered as a reliable alternative to the histochemical technique.
